Fingerprint
Dive into the research topics of 'A phase II clinical trial of ZD1839 (Iressa™) in combination with docetaxel as first-line treatment in patients with advanced breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically